These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28295741)

  • 1. Reactivity Patterns of (Protonated) Compound II and Compound I of Cytochrome P450: Which is the Better Oxidant?
    Li XX; Postils V; Sun W; Faponle AS; Solà M; Wang Y; Nam W; de Visser SP
    Chemistry; 2017 May; 23(26):6406-6418. PubMed ID: 28295741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug metabolism by cytochrome p450 enzymes: what distinguishes the pathways leading to substrate hydroxylation over desaturation?
    Ji L; Faponle AS; Quesne MG; Sainna MA; Zhang J; Franke A; Kumar D; van Eldik R; Liu W; de Visser SP
    Chemistry; 2015 Jun; 21(25):9083-92. PubMed ID: 25924594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What factors influence the rate constant of substrate epoxidation by compound I of cytochrome P450 and analogous iron(IV)-oxo oxidants?
    Kumar D; Karamzadeh B; Sastry GN; de Visser SP
    J Am Chem Soc; 2010 Jun; 132(22):7656-67. PubMed ID: 20481499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantum Mechanics/Molecular Mechanics Studies on the Relative Reactivities of Compound I and II in Cytochrome P450 Enzymes.
    Postils V; Saint-André M; Timmins A; Li XX; Wang Y; Luis JM; Solà M; de Visser SP
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of perferryl-oxo oxidant in alkane hydroxylation catalyzed by cytochrome P450: a hybrid density functional study.
    Isobe H; Yamaguchi K; Okumura M; Shimada J
    J Phys Chem B; 2012 Apr; 116(16):4713-30. PubMed ID: 22510212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Account on Aromatic Hydroxylation by a Cytochrome P450 Model Compound I: A Low-Pressure Mass Spectrometry and Computational Study.
    Cantú Reinhard FG; Sainna MA; Upadhyay P; Balan GA; Kumar D; Fornarini S; Crestoni ME; de Visser SP
    Chemistry; 2016 Dec; 22(51):18608-18619. PubMed ID: 27727524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview on theoretical studies discriminating the two-oxidant versus two-state-reactivity models for substrate monoxygenation by cytochrome P450 enzymes.
    de Visser SP; Porro CS; Quesne MG; Sainna MA; Munro AW
    Curr Top Med Chem; 2013; 13(18):2218-32. PubMed ID: 24047138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One oxidant, many pathways: a theoretical perspective of monooxygenation mechanisms by cytochrome P450 enzymes.
    Shaik S; de Visser SP; Kumar D
    J Biol Inorg Chem; 2004 Sep; 9(6):661-8. PubMed ID: 15365903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What factors affect the regioselectivity of oxidation by cytochrome p450? A DFT study of allylic hydroxylation and double bond epoxidation in a model reaction.
    de Visser SP; Ogliaro F; Sharma PK; Shaik S
    J Am Chem Soc; 2002 Oct; 124(39):11809-26. PubMed ID: 12296749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly reactive electrophilic oxidants in cytochrome P450 catalysis.
    Newcomb M; Chandrasena RE
    Biochem Biophys Res Commun; 2005 Dec; 338(1):394-403. PubMed ID: 16168951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fundamental differences of substrate hydroxylation by high-valent iron(IV)-oxo models of cytochrome P450.
    Tahsini L; Bagherzadeh M; Nam W; de Visser SP
    Inorg Chem; 2009 Jul; 48(14):6661-9. PubMed ID: 19469505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
    Sharma PK; De Visser SP; Ogliaro F; Shaik S
    J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The elusive oxidant species of cytochrome P450 enzymes: characterization by combined quantum mechanical/molecular mechanical (QM/MM) calculations.
    Schöneboom JC; Lin H; Reuter N; Thiel W; Cohen S; Ogliaro F; Shaik S
    J Am Chem Soc; 2002 Jul; 124(27):8142-51. PubMed ID: 12095360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction.
    Jones JP; Mysinger M; Korzekwa KR
    Drug Metab Dispos; 2002 Jan; 30(1):7-12. PubMed ID: 11744605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The valence bond way: reactivity patterns of cytochrome P450 enzymes and synthetic analogs.
    Shaik S; Lai W; Chen H; Wang Y
    Acc Chem Res; 2010 Aug; 43(8):1154-65. PubMed ID: 20527755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of halogenated alkanes by cytochrome P450 enzymes. Aerobic oxidation versus anaerobic reduction.
    Ji L; Zhang J; Liu W; de Visser SP
    Chem Asian J; 2014 Apr; 9(4):1175-82. PubMed ID: 24501011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How external perturbations affect the chemoselectivity of substrate activation by cytochrome P450 OleT
    Chowdhury AS; Ali HS; Faponle AS; de Visser SP
    Phys Chem Chem Phys; 2020 Dec; 22(46):27178-27190. PubMed ID: 33226036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical investigation of C--H hydroxylation by (N4Py)Fe(IV)=O(2+): an oxidant more powerful than P450?
    Kumar D; Hirao H; Que L; Shaik S
    J Am Chem Soc; 2005 Jun; 127(22):8026-7. PubMed ID: 15926822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.